Munafa Stock Market Course + Intraday & FNO calls 
Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Protagonist Therapeutics (PTGX)
Technical Analysis Report for NASDAQ stock PTGX Protagonist Therapeutics. Dated: 14 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics then click here. or read Experts views on Protagonist Therapeutics or Forecast & share price targets of Protagonist Therapeutics
Protagonist Therapeutics Opened at 150.23 and Closed at: 147.78, which is -0.27% of previous session's close. It moved within a range of 146.83 and 151.24
The session was a Bearish session with an average volume of 608000, which is 21.38% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 8 days back on short term averages
Support for tomorrow is 145.1 and resistance for tomorrow is 149.51
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 145.99, 144.21 resistance for tomorrow's hourly charts is 150.4, 153.03
10 Day SMA for Protagonist Therapeutics (PTGX) is 146.7 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Protagonist Therapeutics (PTGX) is 149.68 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Protagonist Therapeutics (PTGX) is 143.28 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 124.76 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Protagonist Therapeutics is 107.81 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Protagonist Therapeutics is at 149.68 and 200 DMA is at 107.81, while 50 DMA and 100 DMA are at 143.28 and 124.76 respectively
Protagonist Therapeutics (PTGX) moving average of 20 SMA is at 149.68 and 20 EMA is at 147.25
| Date | Closing Price | 20 SMA | 20 EMA |
| 14 Mon Sep | 147.78 | 149.68 | 147.25 |
| 11 Fri Sep | 148.18 | 150.04 | 147.19 |
| 10 Thu Sep | 145.16 | 150.21 | 147.09 |
| 09 Wed Sep | 145.09 | 150.55 | 147.29 |
| 08 Tue Sep | 145.94 | 150.71 | 147.52 |
| 04 Fri Sep | 145.72 | 150.91 | 147.69 |
Protagonist Therapeutics (PTGX) moving average of 50 SMA is at 143.28 and 50 EMA is at 140.97
| Date | Closing Price | 50 SMA | 50 EMA |
| 14 Mon Sep | 147.78 | 143.28 | 140.97 |
| 11 Fri Sep | 148.18 | 142.95 | 140.69 |
| 10 Thu Sep | 145.16 | 142.62 | 140.38 |
| 09 Wed Sep | 145.09 | 142.22 | 140.18 |
| 08 Tue Sep | 145.94 | 141.77 | 139.98 |
| 04 Fri Sep | 145.72 | 141.28 | 139.74 |
Protagonist Therapeutics (PTGX) moving average of 100 SMA is at 124.76 and 100 EMA is at 129.11
| Date | Closing Price | 100 SMA | 100 EMA |
| 14 Mon Sep | 147.78 | 124.76 | 129.11 |
| 11 Fri Sep | 148.18 | 124.31 | 128.73 |
| 10 Thu Sep | 145.16 | 123.88 | 128.34 |
| 09 Wed Sep | 145.09 | 123.49 | 128 |
| 08 Tue Sep | 145.94 | 123.1 | 127.65 |
| 04 Fri Sep | 145.72 | 122.7 | 127.28 |
Protagonist Therapeutics (PTGX) moving average of 200 SMA is at 107.81 and 200 EMA is at 111.65
| Date | Closing Price | 200 SMA | 200 EMA |
| 14 Mon Sep | 147.78 | 107.81 | 111.65 |
| 11 Fri Sep | 148.18 | 107.52 | 111.29 |
| 10 Thu Sep | 145.16 | 107.23 | 110.92 |
| 09 Wed Sep | 145.09 | 106.95 | 110.57 |
| 08 Tue Sep | 145.94 | 106.65 | 110.22 |
| 04 Fri Sep | 145.72 | 106.34 | 109.86 |
Xbiotech Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Xbiotech Inc, about 0.77% more returns!
Voyager Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Voyager Therapeutics, about 5.59% more returns!
Vtv Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Vtv Therapeutics, about 7.25% more returns!
Rockwell Medical has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Rockwell Medical, about 10.7% more returns!
Natera Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Natera Inc, about 15.6% more returns!
Mannkind Corporation has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Mannkind Corporation, about 2.74% more returns!
Protagonist Therapeutics has performed better than Lexicon Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Liquidia Technologies in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Karyopharm Therapeutics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Inc Research has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Inc Research, about 463.67% more returns!
Protagonist Therapeutics has performed better than Genprex Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Biolinerx in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Axogen Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Atricure Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Atricure Inc, about 31.44% more returns!
Ascendis Pharma has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Ascendis Pharma, about 13.96% more returns!
Aldeyra Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Aldeyra Therapeutics, about 0.42% more returns!
Arbutus Biopharma has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Arbutus Biopharma, about 15.75% more returns!
Protagonist Therapeutics Technical analysis of indicators
Price action analysis of Protagonist Therapeutics (PTGX) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Protagonist Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Protagonist Therapeutics in short term but the sell signal is initial and weak.
Protagonist Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Protagonist Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Protagonist Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 146.61 and Protagonist Therapeutics PTGX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Protagonist Therapeutics PTGX stock. Volume based technical analysis of Protagonist Therapeutics PTGX stock is negative.
Protagonist Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PTGX Experts View which covers a lot of information including buying and selling signals
PTGX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Protagonist Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
